Fast Five Quiz: Ketamine

Mary L Windle, PharmD

Disclosures

May 23, 2019

Ketamine has captured headlines with its potential role in treating certain mental health conditions. This includes approval of esketamine, the S-enantiomer of racemic ketamine, by the US Food and Drug Administration for use in patients with treatment-resistant depression. Evidence also supports the use of intravenous (IV) ketamine for acute pain, including as monotherapy and as an adjunct to opioids. Much remains unclear about ketamine use, however, including potential long-term side effects. With more patients inquiring about the drug, are you familiar with key aspects, including new guidelines and potential interactions? Test your knowledge with this short quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....